Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

1.90
Delayed Data
As of Jan 20
 +0.05 / +2.70%
Today’s Change
1.10
Today|||52-Week Range
3.35
+40.74%
Year-to-Date
Teladoc Announces Stock Sale to Finance Growing Business
Jan 18 / Zacks.com - Paid Partner Content
VCA Looks to Gain Scale and Size by Being Part of Mars
Jan 12 / Zacks.com - Paid Partner Content
Teladoc's Client UnitedAg Expands Pact to Get Wider Services
Jan 13 / Zacks.com - Paid Partner Content
Teladoc (TDOC) Guidance Reflects Solid Business in '16, '17
Jan 11 / Zacks.com - Paid Partner Content
The Advisory Board (ABCO) in Focus: Stock Surges 16.2%
Jan 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.85
Today’s open1.85
Day’s range1.70 - 1.94
Volume147,379
Average volume (3 months)134,142
Market cap$35.9M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-8.89%
Earnings growth (this year)+43.88%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+76.87%
P/E ratioNM
Price/Sales1.88
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
INISInternational Isotop...0.000.00%
TRILTrillium Therapeutic...-0.10-1.96%
GALTGalectin Therapeutic...0.000.00%
BMRABiomerica Inc+0.20+8.44%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$18.0M
Annual profit (last year)-$20.2M
Net profit margin-111.88%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Chief Operating Officer &
Executive VP-Finance
John A. Roberts
Corporate headquarters
Rutherford, New Jersey

Forecasts


Search for Jobs